References
- Carmeliet P, Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature 407:249–57.
- Deng T, Peng Y, Zhang R, et al. (2017). Water-solubilizing hydrophobic ZnAgInSe/ZnS QDs with tumor-targeted cRGD-sulfobetaine-PIMA-histamine ligands via a self-assembly strategy for bioimaging. ACS Appl Mater Interfaces 9:11405–14.
- Duan X, Xiao J, Yin Q, et al. (2013). Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–69.
- Endres T, Zheng M, Beck-Broichsitter M, et al. (2012). Optimising the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation techniques. J Control Release 160:583–91.
- Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100:57–70.
- Heldin CH, Rubin K, Pietras K, et al. (2004). High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4:806–13.
- Huo M, Zhao Y, Satterlee AB, et al. (2017). Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. J Control Release 245:81–94.
- Jia J, Zhu F, Ma X, et al. (2009). Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 8:111–28.
- Ju C, Mo R, Xue J, et al. (2014). Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration. Angew Chem Int Ed Engl 53:6253–8.
- Kitano H. (2007). A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 5:202–10.
- Leu AJ, Berk DA, Lymboussaki A, et al. (2000). Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–7.
- Li P, Zhou X, Qu D, et al. (2017). Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2. Drug Deliv 24:834–45.
- Li SD, Huang L. (2010). Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release 145:178–81.
- Lv S, Tang Z, Li M, et al. (2014). Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials 35:6118–29.
- Matsubara T, Otani R, Yamashita M, et al. (2017). Selective intracellular delivery of ganglioside GM3-binding peptide through caveolae/raft-mediated endocytosis. Biomacromolecules 18:355–62.
- Medina C, Santos-Martinez M, Radomski A, et al. (2007). Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150:552–8.
- Miao L, Huang L. (2015). Exploring the tumor microenvironment with nanoparticles. In: Miao L, Huang L ed. Nanotechnology-based precision tools for the detection and treatment of cancer. Basel: Springer, 193–226.
- Miller MA, Chandra R, Cuccarese MF, et al. (2017). Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascularbursts. Sci Transl Med 9:eaal0225.
- Mo R, Jiang T, DiSanto R, et al. (2014). ATP-triggered anticancer drug delivery. Nat Commun 5:3364.
- Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318.
- Mukherjee A, Samanta S, Karmakar P. (2011). Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage. Mutat Res 715:42–51.
- Netti PA, Berk DA, Swartz MA, et al. (2000). Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60:2497–503.
- Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60.
- Qu D, He J, Liu C, et al. (2014). Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation. Int J Nanomedicine 9:109–19.
- Qu D, Lin H, Zhang N, et al. (2013). In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr Polym 92:545–54.
- Qu D, Ma Y, Sun W, et al. (2015). Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells. Int J Nanomedicine 10:1173–87.
- Qu D, Wang L, Liu M, et al. (2017). Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment. Biomacromolecules 18:1268–80.
- Shi J, Votruba AR, Farokhzad OC, et al. (2010). Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10:3223–30.
- Su Z, Xing L, Chen Y, et al. (2014). Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm 11:1823–34.
- Tong K, Xin C, Chen W. (2017). Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway. Oncol Lett 13:518–24.
- Wang H, Zhao Y, Wu Y, et al. (2011). Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32:8281–90.
- Wilhelm S, Tavares AJ, Dai Q, et al. (2016). Analysis of nanoparticle delivery to tumours. Nat Rev Mater 1:16014.
- Xiong XB, Lavasanifar A. (2011). Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 5:5202–13.
- Xu X, Xie K, Zhang XQ, et al. (2013). Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proc Natl Acad Sci USA 110:18638–43.
- Yehia R, Hathout RM, Attia DA, et al. (2017). Anti-tumor efficacy of an integrated methyl dihydrojasmonate transdermal microemulsion system targeting breast cancer cells: in vitro and in vivo studies. Colloids Surf B Biointerfaces 155:512–21.
- Zhang H, Jiang W, Liu R, et al. (2017). Rational design of metal organic framework nanocarrier-based codelivery system of doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy. ACS Appl Mater Interfaces 9:19687–97.
- Zhao H, Li Q, Hong Z. (2016). Paclitaxel-loaded mixed micelles enhance ovarian cancer therapy through extracellular pH-triggered PEG detachment and endosomal escape. Mol Pharm 13:2411–22.
- Zhong P, Qiu M, Zhang J, et al. (2017). cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma. Nanotechnology 28:295103.